Prevention & Chronic Conditions

Broadcast

e-SPACE CRM 2026 – Day Two

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

Broadcast

e-SPACE CRM 2026 – Day One

Shelley Zieroth, Shahzeb Khan, João Pedro Ferreira

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Role of the Thyroid System in the Dynamic Complex Network of Cardioprotection

Citation:

European Cardiology Review 2016;11(1):36–42

The Role of Ivabradine and Trimetazidine in the New ESC HF Guidelines

Citation:

Cardiac Failure Review, 2016;2(2):123–9

Left Ventricular Remodelling: A Problem in Search of Solutions

Citation:

European Cardiology Review 2016;11(1):29–35

Controversy Surrounding ROCKET-AF: A Call for Transparency, But Should We Be Changing Practice?

Citation:

Arrhythmia & Electrophysiology Review 2016;5(1):12–3